doi: 10.1016/0090-8258(91)90254-3.
Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity
Affiliations
- PMID: 2026360
- DOI: 10.1016/0090-8258(91)90254-3
Item in Clipboard
Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity
Gynecol Oncol.
1991 Apr.
Abstract
Recombinant human tumor necrosis factor (rHuTNF) is a macrophage-secretory protein with antitumor activity. In vivo and in vitro cytotoxicity studies have been carried out to test the effectiveness of rHuTNF alone or in combination with chemotherapeutic agents. We have evaluated the direct cytotoxic effect of rHuTNF on a human epithelial ovarian cancer cell line in vitro (A2774), alone, or in combination with mitoxantrone (Mit), a topoisomerase II (Topo II) targeted drug. Our results not only suggest that rHuTNF is directly cytotoxic, but also that it is able to induce a very strong potentiation of Mit cytotoxicity.
Similar articles
-
Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.Jpn J Cancer Res. 1992 Jul;83(7):684-7. doi: 10.1111/j.1349-7006.1992.tb01966.x. Jpn J Cancer Res. 1992. PMID: 1517145 Free PMC article.
-
Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.Jpn J Cancer Res. 1992 Nov;83(11):1132-6. doi: 10.1111/j.1349-7006.1992.tb02735.x. Jpn J Cancer Res. 1992. PMID: 1336489 Free PMC article.
-
Augmentation of antineoplastic effects by the combination of recombinant human tumor necrosis factor and mitoxantrone on primary culture of human ovarian cancer cells.Anticancer Res. 1992 Sep-Oct;12(5):1411-4. Anticancer Res. 1992. PMID: 1444198
-
Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.Oncol Res. 1993;5(8):311-23. Oncol Res. 1993. PMID: 8012063
-
Synergistic cytotoxic effects of recombinant human tumor necrosis factor and Etoposide (VP16) or Doxorubicin on A2774 human epithelial ovarian cancer cell line.Int J Gynecol Cancer. 1992 May;2(3):147-151. doi: 10.1046/j.1525-1438.1992.02030147.x. Int J Gynecol Cancer. 1992. PMID: 11576250
Cited by
-
Potentiation by tumor necrosis factor of mitoxantrone cytotoxicity to human ovarian cancer cell lines.Jpn J Cancer Res. 1992 Jul;83(7):684-7. doi: 10.1111/j.1349-7006.1992.tb01966.x. Jpn J Cancer Res. 1992. PMID: 1517145 Free PMC article.
-
Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.Jpn J Cancer Res. 1992 Nov;83(11):1132-6. doi: 10.1111/j.1349-7006.1992.tb02735.x. Jpn J Cancer Res. 1992. PMID: 1336489 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical